bioRxivCancer BiologyPreprint
Selective covalent-allosteric tools to dissect Akt2
Lena QuambuschiD, Giovanni Danilo D’AngeloiD, Tonia KirschneriD, Maria BeerbaumiD, Laura DeptaiD, Fabian Schnecke, Janina NiggenaberiD, Sven Brandherm, Jörn WeisneriD, Matthias Philipp MülleriD, Leif DehmeltiD, Daniel RauhiD
Abstract
The protein kinase Akt and its isoforms play a crucial role in various diseases. Unique functions of the individual isoforms (Akt1, Akt2, Akt3) might be essential for survival in malignancies. Particularly for Akt2, it was reported that a knock-out led to diabetic phenotype and might be correlated with clinically adverse hyperglycemic effects observed in pan Akt-treatment. Enduring failure of Akt inhibitors in the clinic indicates the necessity for a thorough understanding of the underlying biology, preferably by using highly isoform-selective small molecules. Here we report the structure-guided development of Akt2-selective covalent-allosteric probe molecules, that can be successfully modified within a complex environment using biorthogonal chemistry. Thus, enabling first Akt2-specific pull-down studies and the use in functional studies, such as selective fluorescent labeling in cellular systems. These chemical probes expand our toolbox to dissect the critical questions of Akt2s function in health and disease, thereby paving the way for novel therapeutic strategies based on thorough mechanistic insights.
- research focus: drug response / drug discovery
- research focus: cell type annotation
- research focus: protein folding & dynamics
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting
Francesco A. Greco, Andreas Krämer, … Stefan Knapp·European Journal of Medicinal ChemistryPeer-reviewed·Jul 14, 2024
- Live-cell NanoBRET assay to measure AKT inhibitor binding to conformational states of AKT
Jeremy W. Harris, Flávio Antônio de Oliveira Simões, … William M. Marsiglia·ACS Chemical BiologyPeer-reviewed·Jul 9, 2025
- Molecular Dynamics-Guided Design and Chemoproteomic Profiling of Covalent Kinase Activity Probes
Pratyasha Chakraborty, Anthony J. Carlos, … Raymond E. Moellering·bioRxiv·Oct 17, 2025
- Identification of CK2α' selective inhibitors by the screening of an allosteric-kinase-inhibitor-like compound library
D. Mudaliar, R. H. Mansky, … R. Gomez-Pastor·bioRxiv·Jan 18, 2024
- Proposed allosteric inhibitors bind to the ATP site of CK2α
Paul Brear, Darby Ball, … Marko Hyvonen·Journal of Medicinal ChemistryPeer-reviewed·Oct 29, 2020
- Discovery of an IKK2 Site that Allosterically Controls Its Activation
S. J. Hotchkiss, M. C. Mulero, … G. Ghosh·bioRxiv·Jan 27, 2021